U.S. Pharmaceutical Isolators Market Size, Share & Trends Analysis Report By Type (Open Isolator, Close Isolator), By Pressure (Positive Pressure, Negative Pressure), And Segment Forecasts, 2020 - 2028
This report can be delivered to the clients within 48 Business Hours
U.S. Pharmaceutical Isolators Market Growth & Trends
The U.S. pharmaceutical isolators market size is expected to reach USD 205.2 million by 2028, registering a CAGR of 5.8% from 2020 to 2028, according to a new report by Grand View Research, Inc. The rapid growth of the pharmaceutical industry in the U.S. and advancements in technologies used in the industry are anticipated to have a positive impact on market growth.
The growth of the industry in the U.S. is primarily driven by continuous progress in the field of medicines and bioscience. The rising demand for aseptically processed parenteral medicines, along with increased investments in the industry, is anticipated to drive the market in the U.S.
Pharmaceutical isolators are seeing fast-paced technological advancements in aseptic processing in terms of incorporation of robotics and automation solutions and industry 4.0. By integrating robotics within gloveless pharmaceutical isolators, the risk of microbe contamination, as well as particle contamination caused by human intervention is reduced.
The industry is moving toward energy efficiency and sustainability. Pharmaceutical isolators offer higher energy efficiency as compared to the Restricted Access Barrier System (RABS). Energy saving in pharmaceutical isolators can be up to 65% as compared to 30% offered by RABS which is likely to positively improve their demand.
U.S. Pharmaceutical Isolators Market Report Highlights
U.S. Pharmaceutical Isolators Market Growth & Trends
The U.S. pharmaceutical isolators market size is expected to reach USD 205.2 million by 2028, registering a CAGR of 5.8% from 2020 to 2028, according to a new report by Grand View Research, Inc. The rapid growth of the pharmaceutical industry in the U.S. and advancements in technologies used in the industry are anticipated to have a positive impact on market growth.
The growth of the industry in the U.S. is primarily driven by continuous progress in the field of medicines and bioscience. The rising demand for aseptically processed parenteral medicines, along with increased investments in the industry, is anticipated to drive the market in the U.S.
Pharmaceutical isolators are seeing fast-paced technological advancements in aseptic processing in terms of incorporation of robotics and automation solutions and industry 4.0. By integrating robotics within gloveless pharmaceutical isolators, the risk of microbe contamination, as well as particle contamination caused by human intervention is reduced.
The industry is moving toward energy efficiency and sustainability. Pharmaceutical isolators offer higher energy efficiency as compared to the Restricted Access Barrier System (RABS). Energy saving in pharmaceutical isolators can be up to 65% as compared to 30% offered by RABS which is likely to positively improve their demand.
U.S. Pharmaceutical Isolators Market Report Highlights
- The closed isolators segment is expected to witness a CAGR of 5.5% from 2020 to 2028 owing to the ability to operate without personnel access to the critical zone, making them suitable for application in the preparation of toxic materials
- The positive pressure segment accounted for 53.9% of the overall revenue share in 2020, owing to its demand in sterile processes when the process is of particular significance and keeping any contaminants out of the isolator is a priority
- Companies are collaborating with educational institutions along with their in-house R&D facilities for developing processes and technologies that offer a sustainable advantage in the future
- In February 2021, Comecer S.p.A partnered with Illuminate Manufacturing Intelligence, to integrate Illuminate, a pharmaceutical production solution based on industry 4.0, to get real-time updates of their manufacturing equipment
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Research Methodology
1.2. Research Scope and Assumptions
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources & Third-Party Perspectives
1.3.4. Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segmental Outlook
2.3. Competitive Insights
CHAPTER 3. U.S. PHARMACEUTICAL ISOLATORS MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Segmentation & Scope
3.2. Market Lineage Outlook
3.3. Penetration & Growth Prospect Mapping
3.4. Industry Value Chain Analysis
3.5. Regulatory Framework
3.6. U.S.Pharmaceutical Isolators Market - Market dynamics
3.6.1. Market Driver Analysis
3.6.2. Market Restraint Analysis
3.7. Business Environment Analysis
3.7.1. Industry Analysis - Porter’s
3.7.1.1. Supplier Power
3.7.1.2. Buyer Power
3.7.1.3. Substitution Threat
3.7.1.4. Threat from New Entrant
3.7.1.5. Competitive Rivalry
3.7.2. PESTEL Analysis
3.7.2.1. Political Landscape
3.7.2.2. Environmental Landscape
3.7.2.3. Social Landscape
3.7.2.4. Technology Landscape
3.7.2.5. Economic Landscape
3.7.2.6. Legal Landscape
CHAPTER 4. U.S. PHARMACEUTICAL ISOLATORS MARKET: TYPE ESTIMATES & TREND ANALYSIS
4.1. U.S. Pharmaceutical Isolators Market: Product Movement Analysis, 2020 & 2028
4.2. Open Isolator
4.2.1. Market estimates and forecasts, 2017 - 2028 (USD Million)
4.3. Closed Isolator
4.3.1. Market estimates and forecasts, 2017 - 2028 (USD Million)
CHAPTER 5. U.S. PHARMACEUTICAL ISOLATORS MARKET: PRESSURE ESTIMATES & TREND ANALYSIS
5.1. U.S. Pharmaceutical Isolators Market: Pressure Movement Analysis, 2020 & 2028
5.2. Positive Pressure
5.2.1. Market estimates and forecasts, 2017 - 2028 (USD Million)
5.3. Negative Pressure
5.3.1. Market estimates and forecasts, 2017 - 2028 (USD Million)
CHAPTER 6. U.S. PHARMACEUTICAL ISOLATORS MARKET: COMPETITIVE ANALYSIS
6.1. Key Players & Recent Developments & Their Impact on the Industry
6.2. Key Company/Competition Categorization
6.3. Vendor Landscape
6.4. Company Market Position Analysis
6.5. List of Key Private Companies and Their Geographical Presence
CHAPTER 7. COMPANY PROFILES
7.1. COMECER S.p.A.
7.1.1. Company Overview
7.1.2. Financial Performance
7.1.3. Product Benchmarking
7.1.4. Strategic Initiatives
7.2. LAF Technologies
7.2.1. Company Overview
7.2.2. Financial Performance
7.2.3. Product Benchmarking
7.2.4. Strategic Initiatives
7.3. Iso Tech Design
7.3.1. Company Overview
7.3.2. Financial Performance
7.3.3. Product Benchmarking
7.3.4. Strategic Initiatives
7.4. Nuaire
7.4.1. Company Overview
7.4.2. Financial Performance
7.4.3. Product Benchmarking
7.4.4. Strategic Initiatives
7.5. Getinge AB
7.5.1. Company Overview
7.5.2. Financial Performance
7.5.3. Product Benchmarking
7.5.4. Strategic Initiatives
7.6. SKAN AG
7.6.1. Company Overview
7.6.2. Financial Performance
7.6.3. Product Benchmarking
7.6.4. Strategic Initiatives
7.7. M. BRAUN INERTGAS-SYSTEME GMBH
7.7.1. Company Overview
7.7.2. Financial Performance
7.7.3. Product Benchmarking
7.7.4. Strategic Initiatives
7.8. AZBIL TELSTAR, S.L.U.
7.8.1. Company Overview
7.8.2. Financial Performance
7.8.3. Product Benchmarking
7.8.4. Strategic Initiatives
7.9. Syntegon Technologies GmbH
7.9.1. Company Overview
7.9.2. Financial Performance
7.9.3. Product Benchmarking
7.9.4. Strategic Initiatives
7.10. IMA Group
7.10.1. Company Overview
7.10.2. Financial Performance
7.10.3. Product Benchmarking
7.10.4. Strategic Initiatives
1.1. Research Methodology
1.2. Research Scope and Assumptions
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources & Third-Party Perspectives
1.3.4. Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segmental Outlook
2.3. Competitive Insights
CHAPTER 3. U.S. PHARMACEUTICAL ISOLATORS MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Segmentation & Scope
3.2. Market Lineage Outlook
3.3. Penetration & Growth Prospect Mapping
3.4. Industry Value Chain Analysis
3.5. Regulatory Framework
3.6. U.S.Pharmaceutical Isolators Market - Market dynamics
3.6.1. Market Driver Analysis
3.6.2. Market Restraint Analysis
3.7. Business Environment Analysis
3.7.1. Industry Analysis - Porter’s
3.7.1.1. Supplier Power
3.7.1.2. Buyer Power
3.7.1.3. Substitution Threat
3.7.1.4. Threat from New Entrant
3.7.1.5. Competitive Rivalry
3.7.2. PESTEL Analysis
3.7.2.1. Political Landscape
3.7.2.2. Environmental Landscape
3.7.2.3. Social Landscape
3.7.2.4. Technology Landscape
3.7.2.5. Economic Landscape
3.7.2.6. Legal Landscape
CHAPTER 4. U.S. PHARMACEUTICAL ISOLATORS MARKET: TYPE ESTIMATES & TREND ANALYSIS
4.1. U.S. Pharmaceutical Isolators Market: Product Movement Analysis, 2020 & 2028
4.2. Open Isolator
4.2.1. Market estimates and forecasts, 2017 - 2028 (USD Million)
4.3. Closed Isolator
4.3.1. Market estimates and forecasts, 2017 - 2028 (USD Million)
CHAPTER 5. U.S. PHARMACEUTICAL ISOLATORS MARKET: PRESSURE ESTIMATES & TREND ANALYSIS
5.1. U.S. Pharmaceutical Isolators Market: Pressure Movement Analysis, 2020 & 2028
5.2. Positive Pressure
5.2.1. Market estimates and forecasts, 2017 - 2028 (USD Million)
5.3. Negative Pressure
5.3.1. Market estimates and forecasts, 2017 - 2028 (USD Million)
CHAPTER 6. U.S. PHARMACEUTICAL ISOLATORS MARKET: COMPETITIVE ANALYSIS
6.1. Key Players & Recent Developments & Their Impact on the Industry
6.2. Key Company/Competition Categorization
6.3. Vendor Landscape
6.4. Company Market Position Analysis
6.5. List of Key Private Companies and Their Geographical Presence
CHAPTER 7. COMPANY PROFILES
7.1. COMECER S.p.A.
7.1.1. Company Overview
7.1.2. Financial Performance
7.1.3. Product Benchmarking
7.1.4. Strategic Initiatives
7.2. LAF Technologies
7.2.1. Company Overview
7.2.2. Financial Performance
7.2.3. Product Benchmarking
7.2.4. Strategic Initiatives
7.3. Iso Tech Design
7.3.1. Company Overview
7.3.2. Financial Performance
7.3.3. Product Benchmarking
7.3.4. Strategic Initiatives
7.4. Nuaire
7.4.1. Company Overview
7.4.2. Financial Performance
7.4.3. Product Benchmarking
7.4.4. Strategic Initiatives
7.5. Getinge AB
7.5.1. Company Overview
7.5.2. Financial Performance
7.5.3. Product Benchmarking
7.5.4. Strategic Initiatives
7.6. SKAN AG
7.6.1. Company Overview
7.6.2. Financial Performance
7.6.3. Product Benchmarking
7.6.4. Strategic Initiatives
7.7. M. BRAUN INERTGAS-SYSTEME GMBH
7.7.1. Company Overview
7.7.2. Financial Performance
7.7.3. Product Benchmarking
7.7.4. Strategic Initiatives
7.8. AZBIL TELSTAR, S.L.U.
7.8.1. Company Overview
7.8.2. Financial Performance
7.8.3. Product Benchmarking
7.8.4. Strategic Initiatives
7.9. Syntegon Technologies GmbH
7.9.1. Company Overview
7.9.2. Financial Performance
7.9.3. Product Benchmarking
7.9.4. Strategic Initiatives
7.10. IMA Group
7.10.1. Company Overview
7.10.2. Financial Performance
7.10.3. Product Benchmarking
7.10.4. Strategic Initiatives
LIST OF TABLES
Table 1 Key international regulations
Table 2 U.S. Pharmaceutical Isolator market estimates and forecasts, by open isolator, 2017 - 2028 (USD Million)
Table 3 U.S. Pharmaceutical Isolator market estimates and forecasts, by closed isolator, 2017 - 2028 (USD Million)
Table 4 U.S. pharmaceutical isolator market estimates and forecasts, by positive pressure, 2017 - 2028 (USD Million)
Table 5 U.S. pharmaceutical isolator market estimates and forecasts, by negative pressure, 2017 - 2028 (USD Million)
Table 1 Key international regulations
Table 2 U.S. Pharmaceutical Isolator market estimates and forecasts, by open isolator, 2017 - 2028 (USD Million)
Table 3 U.S. Pharmaceutical Isolator market estimates and forecasts, by closed isolator, 2017 - 2028 (USD Million)
Table 4 U.S. pharmaceutical isolator market estimates and forecasts, by positive pressure, 2017 - 2028 (USD Million)
Table 5 U.S. pharmaceutical isolator market estimates and forecasts, by negative pressure, 2017 - 2028 (USD Million)
LIST OF FIGURES
Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Primary Research Process
Fig. 4 Market Research Approaches - Bottom Up Approach
Fig. 5 Market Research Approaches - Top Down Approach
Fig. 6 Market Research Approaches - Combined Approach
Fig. 7 R&D Spending on Pharmaceuticals Industry in U.S., 2016 - 2019 (USD Billion)
Fig. 8 Market Restraint Analysis
Fig. 9 U.S. Pharmaceutical Isolator Market: Type Movement Analysis, 2020 & 2028
Fig. 10 U.S. Pharmaceutical Isolator Market: Pressure Movement Analysis, 2020 & 2028
Fig. 11 Competitive Dashboard Analysis
Fig. 12 Company Market Position Analysis
Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Primary Research Process
Fig. 4 Market Research Approaches - Bottom Up Approach
Fig. 5 Market Research Approaches - Top Down Approach
Fig. 6 Market Research Approaches - Combined Approach
Fig. 7 R&D Spending on Pharmaceuticals Industry in U.S., 2016 - 2019 (USD Billion)
Fig. 8 Market Restraint Analysis
Fig. 9 U.S. Pharmaceutical Isolator Market: Type Movement Analysis, 2020 & 2028
Fig. 10 U.S. Pharmaceutical Isolator Market: Pressure Movement Analysis, 2020 & 2028
Fig. 11 Competitive Dashboard Analysis
Fig. 12 Company Market Position Analysis
